Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
BACKGROUND
Long-acting inhaled ss(2)-adrenergic agonists (LABAs) are recommended as 'add-on' medication to inhaled corticosteroids (ICS) in the maintenance therapy of asthmatic adults and children aged two years and above.


OBJECTIVE
To quantify in asthmatic patients the safety and efficacy of the addition of LABAs to ICS in patients insufficiently controlled on ICS alone.


METHODS
We identified randomised controlled trials (RCTs) through electronic database searches (the Cochrane Airways Group Specialised Register, MEDLINE, EMBASE and CINAHL), bibliographies of RCTs and correspondence with manufacturers until May 2008.


METHODS
We included RCTs if they compared the addition of inhaled LABAs versus placebo to the same dose of ICS in children aged two years and above and in adults.


METHODS
Two review authors independently assessed studies for methodological quality and extracted data. We obtained confirmation from the trialists when possible. The primary endpoint was the relative risk (RR) of asthma exacerbations requiring rescue oral corticosteroids. Secondary endpoints included pulmonary function tests (PFTs), rescue beta2-agonist use, symptoms, withdrawals and adverse events.


RESULTS
Seventy-seven studies met the entry criteria and randomised 21,248 participants (4625 children and 16,623 adults). Participants were generally symptomatic at baseline with moderate airway obstruction despite their current ICS regimen. Formoterol or salmeterol were most frequently added to low-dose ICS (200 to 400 microg/day of beclomethasone (BDP) or equivalent) in 49% of the studies. The addition of a daily LABA to ICS reduced the risk of exacerbations requiring oral steroids by 23% from 15% to 11% (RR 0.77, 95% CI 0.68 to 0.87, 28 studies, 6808 participants). The number needed to treat with the addition of LABA to prevent one use of rescue oral corticosteroids is 41 (29, 72), although the event rates in the ICS groups varied between 0% and 38%. Studies recruiting adults dominated the analysis (6203 adult participants versus 605 children). The subgroup estimate for paediatric studies was not statistically significant (RR 0.89, 95% CI 0.58 to 1.39) and includes the possibility of the superiority of ICS alone in children.Higher than usual dose of LABA was associated with significantly less benefit. The difference in the relative risk of serious adverse events with LABA was not statistically significant from that of ICS alone (RR 1.06, 95% CI 0.87 to 1.30). The addition of LABA led to a significantly greater improvement in FEV(1) (0.11 litres, 95% 0.09 to 0.13) and in the proportion of symptom-free days (11.88%, 95% CI 8.25 to 15.50) compared to ICS monotherapy. It was also associated with a reduction in the use of rescue short-acting ss(2)-agonists (-0.58 puffs/day, 95% CI -0.80 to -0.35), fewer withdrawals due to poor asthma control (RR 0.50, 95% CI 0.41 to 0.61), and fewer withdrawals due to any reason (RR 0.80, 95% CI 0.75 to 0.87). There was no statistically significant group difference in the risk of overall adverse effects (RR 1.00, 95% 0.97 to 1.04), withdrawals due to adverse health events (RR 1.04, 95% CI 0.86 to 1.26) or any of the specific adverse health events.


CONCLUSIONS
In adults who are symptomatic on low to high doses of ICS monotherapy, the addition of a LABA at licensed doses reduces the rate of exacerbations requiring oral steroids, improves lung function and symptoms and modestly decreases use of rescue short-acting ss(2)-agonists. In children, the effects of this treatment option are much more uncertain. The absence of group difference in serious adverse health events and withdrawal rates in both groups provides some indirect evidence of the safety of LABAs at usual doses as add-on therapy to ICS in adults, although the width of the confidence interval precludes total reassurance.
Ducharme
Francine M
FM
Research Centre, CHU Sainte-Justine and the Department of Pediatrics, University of Montreal, 3175 Cote Sainte-Catherine, Montreal, Québec, Canada, H3T 1C5.
Ni Chroinin
Muireann
M
Greenstone
Ilana
I
Lasserson
Toby J
TJ
D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D000328:Adult; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004359:Drug Therapy, Combination / Q000379:methods; D004983:Ethanolamines / Q000008:administration & dosage; D000068759:Formoterol Fumarate; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D000068299:Salmeterol Xinafoate
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D004983:Ethanolamines; D000068299:Salmeterol Xinafoate; D001507:Beclomethasone; D000420:Albuterol; D000068759:Formoterol Fumarate
Respir Med. 2002 Mar;96(3):155-62
11908511
Can Respir J. 1999 Jan-Feb;6(1):45-51
10202220
Respir Med. 2002 Dec;96(12):1021-5
12477218
Respir Med. 2003 Jun;97(6):702-8
12814158
BMJ. 2003 Oct 18;327(7420):891
14563743
Respir Res. 2007 Jul 14;8:52
17629923
Ugeskr Laeger. 2005 Sep 19;167(38):3595-7
16219190
J Allergy Clin Immunol. 1999 May;103(5 Pt 1):816-22
10329815
Control Clin Trials. 1986 Sep;7(3):177-88
3802833
Am J Med. 2000 Aug 1;109(2):114-21
10967152
Clin Ther. 2006 Jan;28(1):73-85
16490581
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):996-1001
10712354
Allergy Asthma Proc. 1999 May-Jun;20(3):173-80
10389550
Can Respir J. 2001 May-Jun;8(3):147-52
11420590
Allergy. 2006 May;61(5):531-6
16629780
J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):88-92
9893190
Ann Allergy Asthma Immunol. 1999 Mar;82(3):257-65
10094216
Pediatr Allergy Immunol. 2004 Feb;15(1):32-9
14998380
Stat Med. 1996 Dec 15;15(23):2493-507
8961459
Pulm Pharmacol Ther. 2001;14(1):29-34
11162416
Eur Respir J. 1998 Jul;12(1):30-4
9701410
MedGenMed. 2001 Jul 05;3(4):3
11549982
Allergy. 1995 Jan;50(1):28-33
7741186
Chest. 2001 Apr;119(4):1021-6
11296164
Am J Med. 1998 May;104(5):431-8
9626025
Chest. 2001 Aug;120(2):423-30
11502639
J Allergy Clin Immunol. 2002 Jun;109(6):929-35
12063520
Ann Allergy Asthma Immunol. 2002 Aug;89(2):180-90
12197575
Chest. 1999 Mar;115(3):623-8
10084466
Pharmacoeconomics. 2002;20(13):909-18
12381242
N Engl J Med. 1997 Dec 4;337(23):1659-65
9385125
Chest. 1999 Mar;115(3):666-73
10084473
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD006922
19588410
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):827-32
9517598
Thorax. 1990 Apr;45(4):259-61
1972599
Paediatr Drugs. 2003;5(1):63-8; discussion 69
12513109
Presse Med. 2003 Mar 22;32(11):493-7
12733387
Int J Clin Pract. 2003 Oct;57(8):656-61
14627173
Respirology. 1999 Mar;4(1):77-81
10339734
Lung. 1998;176(2):133-9
9500298
N Engl J Med. 1995 Aug 24;333(8):499-506
7623883
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005535
16235410
Am J Respir Crit Care Med. 1999 Aug;160(2):594-9
10430734
Pediatr Allergy Immunol. 1995 May;6(2):103-8
7581719
J Allergy Clin Immunol. 2003 Jul;112(1):72-8
12847482
J Allergy Clin Immunol. 2003 Jan;111(1):57-65
12532097
Lancet. 2001 Jan 27;357(9252):257-61
11214127
Am J Respir Crit Care Med. 2003 May 1;167(9):1232-8
12456382
Chest. 1996 Apr;109(4):953-6
8635376
Respir Med. 2003 Jun;97(6):667-71
12814152
Ann Allergy Asthma Immunol. 1999 Jun;82(6):521-9
10400478
Eur J Pediatr. 1995 Dec;154(12):983-90
8801107
Am J Respir Crit Care Med. 1999 Jan;159(1):79-86
9872822
Respir Med. 2003 Sep;97(9):1067-74
14509562
Pediatrics. 1997 May;99(5):655-9
9113940
Am J Respir Crit Care Med. 1998 Jul;158(1):213-9
9655732
Ann Allergy Asthma Immunol. 1998 Jul;81(1):51-8
9690573
N Engl J Med. 2000 Dec 28;343(26):1902-9
11136260
Clin Ther. 2007 May;29(5):823-843
17697902
Pediatr Pulmonol. 1998 Jan;25(1):1-17
9475326
Respir Med. 2000 Jul;94(7):724-32
10926346
Clin Ther. 2003 Jul;25(7):2022-36
12946548
Pol Merkur Lekarski. 2002 Feb;12(68):99-103
11995262
Respir Med. 2003 Apr;97(4):323-30
12693793
Eur Respir J. 1996 Aug;9(8):1678-83
8866594
BMJ. 1993 Apr 17;306(6884):1034-7
8098238
Chest. 2000 Oct;118(4):1049-58
11035676
Ugeskr Laeger. 1996 Jul 1;158(27):3940-3
8701511
Am J Respir Crit Care Med. 2001 Sep 1;164(5):764-9
11549530
Respir Med. 2003 Nov;97 Suppl D:S20-8
14753248
Pulm Pharmacol Ther. 2007;20(6):691-700
17046300
Chest. 1999 Mar;115(3):629-34
10084467
Clin Drug Investig. 1998;16(3):193-201
18370540
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1493-9
10556111
Ugeskr Laeger. 2000 Jan 24;162(4):493-7
10697447
Ugeskr Laeger. 1995 Jan 2;157(1):36-40
7839545
Eur Respir J. 1992 Oct;5(9):1062-7
1426215
Ann Allergy Asthma Immunol. 2000 Oct;85(4):305-10
11061474
Br J Clin Pharmacol. 2003 Jul;56(1):104-11
12848782
Thorax. 1995 Jul;50(7):724-30
7570405
J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1108-16
10856143
Eur Respir J. 2002 Oct;20(4):859-66
12412676
Eur Respir J. 1999 Nov;14(5):1038-43
10596687
J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):427-35
10069876
Respirology. 2006 May;11(3):276-86
16635085
J Aerosol Med. 1995 Spring;8 Suppl 1:S41-7
10150495
Pol Merkur Lekarski. 2001 Sep;11(63):247-51
11761821
J Allergy Clin Immunol. 2000 Dec;106(6):1088-95
11112891
Respir Med. 1995 Jul;89(6):435-40
7644775
Allergol Immunopathol (Madr). 2001 Jan-Feb;29(1):16-21
11449530
Respir Med. 2007 Aug;101(8):1809-13
17418554
Ann Allergy Asthma Immunol. 2005 Jan;94(1):65-72
15702819
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):527-34
10673196
Ann Allergy Asthma Immunol. 2001 Jun;86(6):633-40
11428735
Chest. 2003 Jul;124(1):42-50
12853500
Am J Respir Crit Care Med. 1996 May;153(5):1481-8
8630590
Arch Dis Child. 2000 Oct;83(4):334-9
10999872
Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1556-61
10228126
Respir Med. 2001 Feb;95(2):136-46
11217910
Eur Respir J. 2002 Jul;20(1):66-72
12166584
Thorax. 2006 Apr;61(4):306-12
16449264
Respir Med. 2001 Jun;95(6):484-90
11421506
Br J Clin Pharmacol. 2003 Nov;56(5):494-500
14651722
J Allergy Clin Immunol. 2003 Nov;112(5 Suppl):S107-11
14586395
Eur Respir J. 2003 Jun;21(6):994-9
12797494
Pneumologie. 2001 May;55(5):253-7
11449612
Swiss Med Wkly. 2004 Jan 24;134(3-4):50-8
14745658
Thorax. 2002 Sep;57(9):791-8
12200524
Curr Med Res Opin. 2008 Jun;24(6):1669-82
18462564
Can Respir J. 1998 Jul-Aug;5(4):261-8
9753527
Respir Med. 1999 Dec;93(12):876-84
10653049
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003137
17054161
Thorax. 1999 Mar;54(3):207-12
10325895
Eur J Clin Pharmacol. 2001 Jan-Feb;56(11):781-91
11294367
Respir Med. 2002 Apr;96(4):250-8
12000004
Am Rev Respir Dis. 1990 Sep;142(3):571-5
1975162
Respir Med. 2001 Jan;95(1):64-70
11207020
Int J Clin Pract. 2002 Jul-Aug;56(6):427-33
12166540
Clin Exp Allergy. 2002 Feb;32(2):264-9
11929492
Drugs. 1991 Nov;42(5):895-912
1723379
Chest. 2000 Apr;117(4):950-3
10767223
Clin Allergy. 1988 Mar;18(2):143-50
3365858
Eur Respir J. 2001 Dec;18(6):928-34
11829098
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD006923
18843738
Biometrics. 1985 Mar;41(1):55-68
4005387
Respir Med. 2003 Nov;97 Suppl D:S10-9
14753247
Respir Med. 2002 Nov;96(11):851-61
12418582
J Allergy Clin Immunol. 1998 Mar;101(3):337-41
9525449
BMJ. 1997 Sep 13;315(7109):629-34
9310563
Respir Med. 1992 Sep;86(5):409-17
1361068
BMJ. 1990 Dec 15;301(6765):1365-8
1980220
Allergy. 1998;53(42 Suppl):20-3
9615842
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1603-7
8970342
Pharmacotherapy. 2002 Feb;22(2):212-26
11837559
Respir Med. 2000 Jul;94(7):715-23
10926345
N Engl J Med. 1992 Nov 12;327(20):1420-5
1357554
Respir Med. 2003 Sep;97(9):1061-6
14509561
Pediatr Pulmonol. 1989;7(2):89-93
2797925
Chest. 2000 Aug;118(2):321-8
10936119
Eur Respir J. 1999 Sep;14(3):627-32
10543286
J Allergy Clin Immunol. 2001 May;107(5):783-9
11344343
Drugs. 2006;66(17):2235-54
17137405
Am Fam Physician. 1997 Aug;56(2):558-62
9262535
Respir Med. 2002 Feb;96(2):95-101
11862965
Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):324-8
8756801
Chest. 1992 Apr;101(4):1019-22
1348219
Chest. 1999 Sep;116(3):625-32
10492263
Chest. 2002 May;121(5):1401-6
12006420
J Asthma. 1999;36(1):97-106
10077139
Thorax. 1997 Jun;52(6):535-9
9227720
Br J Clin Pharmacol. 2003 Jul;56(1):11-7
12848770
Respir Med. 2006 Dec;100(12):2151-9
16701989
Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):688-95
9309980
JAMA. 2001 May 23-30;285(20):2594-603
11368733
J Asthma. 2002 Jun;39(4):291-7
12095178
Am J Respir Crit Care Med. 2004 Oct 15;170(8):836-44
15256389
Am J Respir Crit Care Med. 1998 Sep;158(3):924-30
9731027
Eur Respir J. 1996 Sep;9(9):1885-90
8880107
Arch Dis Child. 1999 Jul;81(1):45-8
10373134
Respir Med. 2003 Mar;97(3):234-41
12645830
Am J Respir Med. 2003;2(3):275-81
14720008
Pediatrics. 2001 Sep;108(3):E48
11533366
Chest. 2002 Jun;121(6):2083-4
12065391
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006924
19370661
BMJ. 1997 May 17;314(7092):1441-6
9167559
Clin Ther. 2001 Sep;23(9):1529-41
11589265
Ann Allergy Asthma Immunol. 1995 Nov;75(5):423-8
7583864
Eur Respir J. 2001 Aug;18(2):262-8
11529282
Ann Allergy Asthma Immunol. 1999 Apr;82(4):383-9
10227337
Eur Respir J. 2002 Dec;20(6):1378-85
12503692
Respir Med. 2000 Jun;94(6):612-21
10921768
Thorax. 1995 May;50(5):497-504
7597661
Chest. 1995 Jul;108(1):36-40
7606988
Chest. 2003 May;123(5):1480-7
12740264
Swiss Med Wkly. 2003 May 31;133(21-22):302-9
12861468
Thorax. 1994 Oct;49(10):971-5
7974313
J Allergy Clin Immunol. 2003 Jul;112(1):29-36
12847476
Lancet. 1994 Jul 23;344(8917):219-24
7913155
Eur J Clin Pharmacol. 2003 May;59(1):11-5
12743669
Ann Allergy Asthma Immunol. 2005 Jul;95(1):66-71
16095144
Eur Respir J. 1995 Sep;8(9):1494-8
8575574
Allergy. 1994 Jul;49(6):421-6
7915501
Chest. 2000 May;117(5):1319-23
10807817
BMC Med Res Methodol. 2002;2:1
11860604
Eur Respir J. 2002 Apr;19(4):611-6
11998988
Chest. 2002 Sep;122(3):763-5
12226008
Pulm Pharmacol Ther. 2008;21(1):152-9
17376722
Allergy Asthma Proc. 2007 Mar-Apr;28(2):204-9
17479606
J Allergy Clin Immunol. 1989 Apr;83(4):811-5
2651509
J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):188-95
9500751
Thorax. 1993 Nov;48(11):1121-4
8296255
Pediatr Allergy Immunol. 2006 Sep;17(6):458-65
16925692
Ann Intern Med. 2006 Nov 7;145(9):692-4
17088583
Am J Respir Crit Care Med. 1999 Mar;159(3):824-8
10051257
Respir Med. 1999 Dec;93(12):863-8
10653047
Pediatr Pulmonol. 2003 Nov;36(5):391-8
14520721
Am J Respir Crit Care Med. 2001 Sep 15;164(6):1047-52
11587995
Int J Clin Pract. 2001 Apr;55(3):164-70
11351769
Respir Med. 2001 Sep;95(9):753-8
11575897
J Allergy Clin Immunol. 2008 Feb;121(2):383-9
17980416
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD005307
19821344
J Allergy Clin Immunol. 2003 Jul;112(1):23-8
12847475
Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1156-60
1443864
JAMA. 1994 May 11;271(18):1412-6
7909853
Pediatr Pulmonol. 2000 Aug;30(2):97-105
10922131
Pharmacoeconomics. 2002;20(3):183-94
11929348
Ann Allergy Asthma Immunol. 2003 Sep;91(3):309-13
14533665
Chest. 2000 Dec;118(6):1576-81
11115442
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006217
18425941
Chest. 2001 May;119(5):1306-15
11348933
N Engl J Med. 1997 Nov 13;337(20):1405-11
9358137
Eur Respir J. 1991 Nov;4(10):1168-73
1687129
Pulm Pharmacol Ther. 2004;17(2):89-95
15123230
J Asthma. 1999 Dec;36(8):703-15
10609625
Eur Respir J. 1991 Nov;4(10):1178-84
1687131
Respir Med. 2002 May;96(5):322-9
12113382
Ann Allergy Asthma Immunol. 1995 Sep;75(3):243-8
7552926
Clin Sci (Lond). 1999 Mar;96(3):253-9
10029561
Pulm Pharmacol Ther. 2003;16(3):147-51
12749830
Ann Allergy Asthma Immunol. 2001 Nov;87(5):420-3
11730186
Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006363
18646149
Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1392-7
11704584
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005076
16235393
Acta Paediatr Jpn. 1998 Jun;40(3):247-51
9695299
J Allergy Clin Immunol. 1999 Jun;103(6):1075-80
10359889
J Asthma. 2003;40(7):815-22
14626338
Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1170-4
7551366
Ann Intern Med. 2008 Jul 1;149(1):33-42
18523132
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001385
17253458
JAMA. 2001 May 23-30;285(20):2583-93
11368732
CMAJ. 2005 Sep 13;173(6 Suppl):S12-4
16157728
Eur Respir J. 1996 Mar;9(3):449-55
8730003
J Aerosol Med. 1995 Summer;8 Suppl 2:S5-10
10155357
Eur Respir J. 2007 Jan;29(1):56-62
17050557
Allergy. 1994 Dec;49(10):827-32
7709991
Chest. 2000 Aug;118(2):313-20
10936118
Pediatr Pulmonol. 2004 Feb;37(2):122-7
14730657
Paediatr Respir Rev. 2004;5 Suppl A:S115-8
14980255
Am J Respir Crit Care Med. 1994 Oct;150(4):1006-11
7921429
Eur Respir J. 2004 Jan;23(1):71-5
14738234
Respir Med. 1999 Jan;93(1):33-8
10464846
Thorax. 2000 Sep;55(9):780-4
10950898
Pediatr Pulmonol. 2002 Nov;34(5):342-50
12357478
J Allergy Clin Immunol. 1992 Nov;90(5):757-65
1430701
Am J Respir Crit Care Med. 2001 Sep 1;164(5):759-63
11549529
Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1887-92
8520751
Curr Med Res Opin. 2004;20(2):225-40
15006018
Am J Respir Crit Care Med. 1995 Jan;151(1):66-70
7812574
Lancet. 1997 Oct 4;350(9083):995-9
9329515
Ann Allergy Asthma Immunol. 2002 Feb;88(2):227-35
11868930
Pulm Pharmacol Ther. 2003;16(5):299-306
12877821
Chest. 2001 Mar;119(3):714-9
11243947
Int J Clin Pract. 2003 Dec;57(10):852-6
14712884
Ann Emerg Med. 2002 Jun;39(6):585-91
12023699
Respir Med. 2003 May;97(5):555-62
12735675
Ann Intern Med. 2006 Jun 20;144(12):904-12
16754916
Rev Pneumol Clin. 2003 Jun;59(3):139-48
13130200
Chest. 1999 Sep;116(3):595-602
10492259
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD007949
19588447
Eur Respir J. 2006 Jun;27(6):1144-51
16455831
Pharmacoeconomics. 2003;21(13):951-89
12959627
Respir Med. 2001 Sep;95(9):740-3
11575895
Eur Ann Allergy Clin Immunol. 2003 Nov;35(9):356-62
14716965
Chest. 2002 Mar;121(3):1002-4
11888994
Clin Exp Allergy. 2002 Jan;32(1):117-25
12002728
J Fam Pract. 1998 Oct;47(4):278-84
9789513
BMJ. 2003 Sep 6;327(7414):557-60
12958120